Last reviewed · How we verify

NCT04802187

Implementation of COVID-19 Testing Strategies in Community Health Centers

Completed NA Results posted Last updated 8 November 2023
What this trial tests

NA trial testing RADx CHCs testing intervention strategy in Covid19 in 6 participants. Completed in 15 July 2022.

Timeline
1 December 2020
Primary endpoint
15 July 2022
15 July 2022

Quick facts

Lead sponsorMassachusetts General Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment6
Start date1 December 2020
Primary completion15 July 2022
Estimated completion15 July 2022
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Massachusetts General Hospital

Who can join

Eligibility, any sex, with Covid19. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Percentage Change in Testing During the Study Compared to Tests Completed Prior to Study Start Primary · 85 weeks post-implementation compared to 35 weeks pre-implementation

Acceleration of covid testing volume during covid surges, estimated as the percent change in weekly covid testing volume trend for each 10% increase in covid cases. A slope value was estimated from a segmented regression model for the entire study period, which was then used to calculate a difference between the post- and pre-implementation periods.

GroupValue95% CI
RADx CHCs Testing Intervention Strategy0.0965.04 – .153
Usual Care Control0.0128-0.003 – 0.028

Sponsor's own description

This project is part of a competitive revision to accelerate COVID-19 testing in underserved populations. The overall aim is to implement strategies to expand COVID testing in hotspot communities in MA, through 6 community health center (CHC)-community partnerships. A base strategy will be implemented at all sites. A tailored strategy unique to local populations will be added and tested in a stepped wedge design.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Implementing expanded COVID-19 testing in Massachusetts community health centers through community partnerships: Protocol for an interrupted time series and stepped wedge study design.
    Kruse GR, Pelton-Cairns L, Taveras EM, Dargon-Hart S, et al · · 2022 · cited 9× · PMID 35533978 · DOI 10.1016/j.cct.2022.106783

Verify or expand the search:

Other recruiting trials for Covid19

Currently open trials in the same condition.

Other Massachusetts General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04802187.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing